Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 92 Antiviral Agents I: Drugs for Non- HIV Viral Infections.

Slides:



Advertisements
Similar presentations
Hepatitis C Treatment in Corrections: New Medicine, New Challenges
Advertisements

Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 9 Antifungal and Antiviral Agents.
Hepatitis C and You  2014 Greenview Hepatitis C Fund All Rights Reserved.
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
1 Pathogenic Viruses Name of virus; what family it belongs to; what disease it causes. –DNA or RNA? Ss or ds? –Characteristics of disease, symptoms. –Viral.
Drugs for Non-HIV Viral Infections Paul Lewis, PharmD Infectious Diseases Pharmacy Resident.
1 Inhibitors of Other Viruses A. RIBAVIRIN Ribavirin (Virazole) is a nucleoside analogue in which a triazolecarboxamide moiety is substituted on place.
Hepatitis C Disease & Treatment.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 40 Antiviral Drugs.
Viral STI’s.
Cheryl Ryan Renee Baker. Hepatitis is the inflammation of the liver caused by a virus. The disease targets liver cells, hepatocytes. There are currently.
Antiviral Drugs.
Antiviral Agents Scott M. Hammer, M.D.. Challenges to the Development of Effective Antiviral Agents Myriad number of agents Need knowledge of replication.
Greenview Hepatitis C Fund Deborah Green Home: Cell: /31/2008.
Anti-viral drugs Viruses have no cell wall and made up of nucleic acid components Viruses containing envelope – antigenic in nature Viruses are obligate.
Wyoming Department of Health Communicable Diseases
September 15, 1997Copyright Robert Rapp, University of Kentucky College of Pharmacy Viral Infections Part 1 and 2 Robert P. Rapp, Pharm. D. Professor College.
Agents in the therapy of DNA and RNA Viruses
Antiviral Agents Upton D. Allen. Outline of Presentation Herpes group agents Anti-influenza agents Anti-hepatitis agents Anti-RSV Immune response modifiers.
Antiviral Agents Restricted spectrum
Common viral infections HERPES VIRUS INFECTIONS The objectives of this lecture:  To know the clinically important HVs.  To know the common characteristics.
Patient Information - Viral Hepatitis B (HBV)
1 30/11/98 Herpes Viruses Cytomegalovirus. 2 30/11/98 Presentation Outline  Structure  Classification  Multiplication  Clinical manifestations  Epidemiology.
BIMM118 Drugs Targeting the CNS Parkinson Epilepsy Hypnotics General Anesthetics Anxiolytics Antidepressants.
Antiviral Drugs Prof. Alhaider, 1431 H Definition: Viral infections depend on the host cells. Therefore, antiviral drugs must block viral entry or exit.
IV. Antihepatitis Agents: Like in AIDS, they are suppressive rather than curative. Among many hepatitis viruses, HBV and HCV are the most common cause.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
Anti-viral Drugs.. Introduction The viral agents kill viruses by inhibiting their ability to replicate, but there are currently only about a dozen such.
Antiviral Agents Scott M. Hammer, M.D.. Challenges to the Development of Effective Antiviral Agents Myriad number of agents Need knowledge of replication.
Antiviral Agents.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 39 Antiviral Drugs.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
Antiviral therapy E.McNamara. Challenges Virus parasitize host cells Target the virus specifically Latency, quiescent phase Is treatment necessary? Efficacy.
The Chain of Infection.
CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.
Blood borne Pathogens. Background  Occupational Safety and Health Administration (OSHA)  Blood borne pathogen standard developed December 6, 1991 
Chapter 33 Cancer, Immune System, and Skin Disorders All items and derived items © 2015, 2011 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved.
Hepatitis is an inflammation of the liver. The condition can be self- limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer WHAT IS.
Antivirals Lect 7,8 Sadia Anjum. Targets for Anti-viral therapy 1. viral attachment to cell and fusion (fusion inhibitors) 2. protein translation in infected.
The head of a pin can hold five hundred million rhinoviruses (cause of the common cold). One sneeze can generate an aerosol of enough cold viruses to infect.
ANTIVIRAL AGENTS.
CHRONIC VIRAL HEPATITIS CAUSES. HEPATITIS B Originally known as “serum hepatitis”. Percutaneous inoculation- long been recognized as the route of transmission.
ANTI-VIRAL AGENTS Sarrah Mitchell Sarrah Mitchell.
Hepatitis B Fahad Alanazi.
What is the difference between HSV-1 and HSV-2? Both types infect the body’s mucosal surfaces, usually mouth or genitals, and then establish latency.
ANTIVIRAL THERAPY DR FATAI OLUYADI USMLEINCLINED.COM 1.
1 Chapter 33 Antivirals, Antimalarials, and Anthelmintics Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier.
Antiviral Agents Dr. Yunita Sari Pane, MS 06 August DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU.
Chapter 14: Bloodborne Pathogens. Bloodborne pathogens are transmitted through contact with blood or other bodily fluids Hepatitis, especially hepatitis.
Viral hepatitis overview Itodo Ewaoche 27/02/2015.
Antiviral agents Hamzeh Elayan
Pharmacology of Antiviral Agents
Antiviral Drugs Viruses are obligate intracellular parasites.
Antiviral drugs.
Antifungal, Antiviral, and Immunizing Agents
Copyright © 2017, Elsevier Inc. All rights reserved.
Antiviral Drugs.
Antiviral drugs Mr. OLORO JOSEPH..
School of Pharmacy, University of Nizwa
Antiviral Drugs Viruses are obligate intracellular parasites.
Antiviral Drugs Chapter 45.
Antiviral Agents.
Community Health Nurse Specialist Southwest region
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Antiviral agents.
Fig. 6.9.
Introduction to Clinical Pharmacology Chapter 11 Antiviral Drugs
Presentation transcript:

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 92 Antiviral Agents I: Drugs for Non- HIV Viral Infections

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.2

3 Antiviral Therapy  Our ability to treat viral infections remains limited  Viruses use biochemical machinery of host cells to reproduce  Difficult to suppress viral replication without doing significant harm to the host  Antivirals suppress biochemical processes unique to viral reproduction

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.4 Herpesvirus  Herpes simplex virus (HSV)  Causes infection of the genitalia, mouth, face, and other sites  Varicella-zoster virus (VZV)  Cause of varicella (chickenpox) and herpes zoster (shingles)

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.5

6 Acyclovir (Zovirax)  Active only against members of the herpesvirus family  Agent of first choice for HSV or VZV infections  Herpes simplex genitalis  Mucocutaneous herpes simplex infections  Varicella-zoster infections

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.7 Acyclovir (Zovirax)  Herpesvirus develops resistance to acyclovir  Decreased thymidine production  Alteration in thymidine kinase  Alteration of viral DNA polymerase

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.8 Acyclovir (Zovirax) – Adverse Effects  Intravenous therapy  Phlebitis  Reversible nephrotoxicity  Oral therapy  Gastrointestinal  Vertigo  Topical  Stinging sensations

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.9 Valacyclovir (Valtrex)  Prodrug form of acyclovir  Herpes zoster  Herpes simplex genitalis  Herpes labialis  In some immunocompromised patients  Thrombotic thrombocytopenic purpural/hemolytic uremic syndrome (TTP/HUS)

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.10 Famciclovir (Famvir)  Prodrug used to treat acute herpes zoster and genital herpes infection  Benefits are equivalent to those of acyclovir  Adverse effects are minimal

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.11 Topical Drugs  Herpes labialis  Penciclovir (Denavir)  Docosanol (Abreva)  Ocular herpes infections  Trifluridine (Viroptic)  Vidarabine (Vir-A)

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.12 Cytomegalovirus Infection  CMV – member of herpesvirus group  Transmitted direct contact with body fluids  50%-80% of Americans age 40 and older harbor the virus  Can remain dormant for life  Immunosuppressed patients at high risk to reactivate dormant virus

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.13 Ganciclovir (Cytovene, Vitrasert)  Synthetic antiviral agent  Uses  Herpes simplex viruses – including CMV  Prevention and treatment of CMV infection in immunocompromised patients  Serious side effects  Granulocytopenia  Thrombocytopenia

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.14 Ganciclovir (Cytovene, Vitrasert)  Adverse effects  Granulocytopenia  Thrombocytopenia  Reproductive toxicity  Nausea, fever, rash, anemia, liver dysfunction, confusion, and other CNS symptoms

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.15 Valganciclovir (Valcyte)  Prodrug version of ganciclovir  Used for CMV retinitis  Oral is just as effective as IV  Adverse effects  Blood dyscrasias Bone marrow suppression Bone marrow suppression Granulocytopenia, anemia, thrombocytopenia Granulocytopenia, anemia, thrombocytopenia

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.16 Valganciclovir (Valcyte)  Adverse effects (cont’d)  Diarrhea, nausea, vomiting  Potential for mutagenesis and carcinogenesis  Direct contact with broken tablet should be avoided  Should be disposed of in the same manner as a cytotoxic drug

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.17 Cidofovir (Vistide)  IV with just one indication – CMV retinitis in patients with AIDS who have failed on ganciclovir or foscarnet  Adverse effects  Nephrotoxicity  Neutropenia  Ocular disorders

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.18 Foscarnet (Foscavir)  IV drug active against all known herpesviruses  Compared with ganciclovir  More difficult to give, less well tolerated, much more expensive  CMV retinitis in patients with AIDS  Acyclovir-resistant mucocutaneous HSV and VZV in immunocompromised host

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.19 Fomivirsen (Vitravene)  Unique drug for treating CMV retinitis with HIV-infected patients who are intolerant of or unresponsive to other drugs  Direct injection into the vitreous humor  Adverse effects  Ocular inflammation

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.20 Drugs for Hepatitis  Viral hepatitis is the most common liver disorder  Millions of Americans are infected  Six different viruses can cause acute hepatitis (A, B, C, D, E, and G)  Only B, C, and D can also cause chronic hepatitis

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.21

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.22 Hepatitis C Virus (HCV)  Differences in HCV – 6 genotypes; more than 50 subtypes  Transmission – primarily through exchange of blood; controversy over sexual transmission  No symptoms, but can transmit  Slow progression can lead to liver failure, cancer, and death  Leading reason for liver transplants  Drugs  Pegylated interferon alfa combined with ribavirin

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.23 Interferon Alfa  Interferon family  Alpha, beta, gamma  Alphas used to treat hepatitis  None can be administered orally  Conventional versus long-acting interferons  Adverse effects  Flu-like symptoms  Neuropsychiatric effects, especially depression

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.24 Ribavirin (Rebetol, Copegus)  Used in combination with subQ peginterferon alfa for treatment of chronic hepatitis C  Adverse effects  Hemolytic anemia  Birth defects – category X

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.25 Hepatitis B Virus (HBV)  1.25 million people have chronic hepatitis B  11,000 require hospitalization for deep fatigue, muscle pain, and jaundice  Chronic infection develops in 3%-5% infected adults  Chronic infection can lead to cirrhosis, hepatic failure, hepatocellular carcinoma, and death  Transmission – blood and semen

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.26 Hepatitis B Virus (HBV)  HBV vaccine  Drugs  Interferon alfa-2b (PEG-Intron)  Peginterferon alfa-2a  Lamivudine (Epivir-HBV)  Adefovir (Hepsera)  Entecavir (Baraclude)  Telbivudine (Tyzeka)

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.27

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.28 Influenza  Serious respiratory tract infection  Major cause of morbidity and mortality worldwide  36,000 deaths/year in the United States  Caused by influenza viruses, which are highly variable and undergo constant evolution  Type A – more infectious than B  Type B

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.29 Influenza Management  Influenza managed by vaccination (primary strategy) and drugs  Drugs  Adamantanes and neuraminidase inhibitors  Vaccines  Influenza vaccines change yearly based on identification of strains by CDC, FDA, and WHO.

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.30 Influenza Vaccine  Two types of flu vaccines  Inactivated influenza vaccine  Live, attenuated influenza vaccine  Protection begins 1-2 weeks after vaccination; generally lasts 6 months or more  Small risk for Guillain-Barré syndrome  Five influenza vaccines on the market

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.31 Influenza Vaccine  Precautions and indications  Acute febrile illness – should defer  Minor illnesses with or without fever do not preclude vaccination  Contraindicated for hypersensitivity to eggs – viruses are grown in eggs  Who should be vaccinated  When should vaccines be given

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.32

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.33 Drugs for Influenza  Neuraminidase Inhibitors  Oseltamivir (Tamiflu)  Zanamivir (Relenza)  Adamantanes  Amantadine (Symmetrel)  Rimantadine (Flumadine)

Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.34 Drugs for Respiratory Syncytial Virus Infection  Ribavirin (inhaled)  Broad-spectrum antiviral drug  Palivizumab (Synagis)  Monoclonal antibody for preventing RSV infection in newborns